Did you know that we are conducting clinical trials for diabetes? The prevalence of type 1 diabetes and type 2 diabetes (especially) has been on the rise in this country, and we still don’t have a cure for either. Conducting clinical trials give us an opportunity to test promising new therapies for diabetes, as well as gaining more insight into how these diseases work. They can also provide a life-changing opportunity for people who’ve exhausted more conventional treatment options.
In essence, the presence of diabetes means that your blood sugar (also known as blood glucose) levels have gotten too high. The human body obtains glucose from food that is consumed. It then produces insulin which is responsible for breaking down the glucose in order to “feed” the cells in the body.
Diabetes Fast Facts
- At least 25.8 million Americans are living with diabetes (just about 8.3 percent of the entire population)
- 18.8 million people have been diagnosed, but at least 7 million are still undiagnosed cases
- An estimated 79 million people 20 or older have pre-diabetes
- Diabetes is a leading cause of heart disease and stroke
With type 1 diabetes (also known as juvenile diabetes), the patient’s immune system produces auto-antibodies which attack the beta cells located in the pancreas. These are the cells which are responsible for producing the body’s supply of insulin. The lack of insulin means that glucose cannot be broken down, and the cells of the body will essentially starve. If you would like to read more about type 1 diabetes (T1D), please visit this page.
With type 2 diabetes (also referred to as adult-onset diabetes), the disease develops as a result of a term we refer to as insulin resistance. Unlike type 1, the patient’s body still produces insulin, it just loses the ability to use this insulin effectively. This is largely the result of a person’s lifestyle, including how they eat and how active they are on a regular basis. If you’d like to read more about type 2 diabetes (T2D), please see this page.
Prediabetes in America
As far as sheer numbers go, diabetes has already breached epidemic proportions in this country. Unfortunately, this pales compared to the number of people predicted to be diagnosed with diabetes over the next two decades. Experts estimate that nearly 80 million Americans have prediabetes, meaning that their blood glucose levels are above average but haven’t yet risen to diabetic levels. Most people aren’t aware that they are developing diabetes, but there are some tell-tale signs to watch out for.
You might wonder what types of problems arise from too much glucose? Unfortunately, diabetes research has shown us that it can cause a whole host of serious problems. High glucose levels causes permanent damage to vital organs and bodily systems, such as the:
People living with diabetes are also a lot more likely to develop further chronic conditions, such as:
- High blood pressure (hypertension)
- Heart disease
Blood tests are one of the preferred methods to test for diabetes. If you are living with some form of the disease, you’ll want to focus on maintaining a healthy and balanced overall lifestyle. That remains one of the most effective ways to manage any form of diabetes. Of course, this will also require regular monitoring of your glucose levels and taking any medications your prescribed.
Diabetes Clinical Trials
Avail Clinical Research is currently conducting a wide array of clinical studies targeted towards certain conditions. You may be eligible to participate in one of our Florida diabetes clinical trials and contribute to the development and approval of a new drug or treatment. As a participant, there is no cost to you at any point during the study and health insurance is not required. Browse our clinical trials being conducted now to find the study best suited for you.
What is Diabetes: A Video Overview
Accredited Resources for Diabetes
If you live near Central Florida, click here to learn more about our next diabetes clinical trial. Also, our sister site, Achieve Clinical Research, conducts diabetes clinical trials in Birmingham, Alabama.